Prodromal angina limits infarct size. A role for ischemic preconditioning

Area of Science:

• Cardiology
• Ischemic heart disease
• Myocardial infarction

Background:

• Experimental studies show ischemic preconditioning protects heart cells from injury.
• The occurrence of ischemic preconditioning in humans is not well understood.
• Prodromal angina may be a clinical indicator of preconditioning.

Purpose of the Study:

• To investigate if new-onset prodromal angina correlates with ischemic preconditioning.
• To determine if prodromal angina limits infarct size in patients experiencing myocardial infarction.

Main Methods:

• Retrospective study of 25 patients with first anterior myocardial infarction treated with thrombolysis.
• Patients were divided into groups with and without prodromal angina (chest pain within 24 hours before infarction).
• Compared infarct size, creatine kinase-MB (CKMB) release, and electrocardiogram (ECG) changes between groups.

Main Results:

• Patients with prodromal angina had significantly lower peak CKMB release and smaller final infarct size compared to those without.
• The area at risk was similar between groups, indicating reduced myocardial damage in the prodromal angina group.
• ECG showed a trend towards fewer Q waves and more sigma R waves in the prodromal angina group.

Conclusions:

• New-onset prodromal angina is associated with significantly smaller infarct size in myocardial infarction patients.
• The findings suggest that prodromal angina may represent a clinical manifestation of ischemic preconditioning in humans.
• This protective effect occurs despite similar reperfusion times and absence of collateral circulation.